Nautilus Biotechnology, Inc. (NAUT)
NASDAQ: NAUT · Real-Time Price · USD
0.7509
-0.0221 (-2.86%)
At close: May 28, 2025, 4:00 PM
0.7425
-0.0084 (-1.12%)
After-hours: May 28, 2025, 4:00 PM EDT
Nautilus Biotechnology Stock Forecast
Stock Price Forecast
According to 3 professional analysts, the 12-month price target for Nautilus Biotechnology stock ranges from a low of $1.75 to a high of $6.00. The average analyst price target of $3.58 forecasts a 376.76% increase in the stock price over the next year.
Price Target: $3.58 (+376.76%)
Analyst Consensus: Hold
* Price targets were last updated on Dec 5, 2024.
Analyst Ratings
The average analyst rating for Nautilus Biotechnology stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Total | 3 | 3 | 3 | 3 | 3 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Goldman Sachs | Goldman Sachs | Hold → Strong Sell Downgrades $2.25 → $1.75 | Hold → Strong Sell | Downgrades | $2.25 → $1.75 | +133.05% | Dec 5, 2024 |
| Guggenheim | Guggenheim | Strong Buy Initiates $6 | Strong Buy | Initiates | $6 | +699.04% | Jun 27, 2024 |
| Jefferies | Jefferies | Strong Buy → Hold Initiates $5 → $3 | Strong Buy → Hold | Initiates | $5 → $3 | +299.52% | Jun 3, 2024 |
| Morgan Stanley | Morgan Stanley | Hold Reiterates $6 | Hold | Reiterates | $6 | +699.04% | Aug 3, 2023 |
| Morgan Stanley | Morgan Stanley | Hold Maintains $8 → $6 | Hold | Maintains | $8 → $6 | +699.04% | Aug 3, 2022 |
Financial Forecast
Revenue This Year
n/a
from 67.12M
Revenue Next Year
n/a
EPS This Year
-0.59
from -0.56
EPS Next Year
-0.71
from -0.59
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | n/a | 5.3M | 17.4M | ||
| Avg | n/a | 2.2M | 13.8M | ||
| Low | n/a | n/a | 10.3M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | 676.5% | ||
| Avg | - | - | 516.4% | ||
| Low | - | - | 359.8% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | -0.57 | -0.65 | -0.69 |
| Avg | -0.59 | -0.71 | -0.73 |
| Low | -0.64 | -0.75 | -0.76 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.